Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.51 per share. | 17 Jan 2025 | 3,458,571 | 9,266,645 (17%) | 6% | 2.5 | 8,681,013 | Common Stock |
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.44 per share. | 17 Jan 2025 | 3,454,575 | 5,314,430 (7%) | 5% | 7.4 | 25,702,038 | Common Stock |
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.44 per share. | 17 Jan 2025 | 1,242,856 | 4,071,574 (6%) | 1% | 7.4 | 9,246,849 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 17 Jan 2025 | 648,000 | 15,715,564 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 17 Jan 2025 | 648,000 | 648,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 17 Jan 2025 | 648,000 | 15,715,564 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 17 Jan 2025 | 648,000 | 648,000 | - | 0 | Class A Common Stock | ||
| AMKOR Tech Inc | James J. Kim | Ten Percent Owner, Member of 10% owner group (5) | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 548,000 | 0 (0%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (7) | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 548,000 | 0 (0%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Agnes C. Kim | Member of 10% owner group (3) | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 548,000 | 10,890,435 (4%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 352,642 | 352,642 | - | - | Restricted Stock Units | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.44 per share. | 17 Jan 2025 | 294,167 | 34,025,319 (50%) | 0% | 7.4 | 2,188,602 | Common Stock |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (7) | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 274,000 | 3,732,475 (1%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | John T. Kim | Ten Percent Owner, Member of 10% owner group (6) | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 274,000 | 4,029,736 (1%) | 0% | 0 | Common Stock | |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 261,546 | 261,546 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 17 Jan 2025 | 261,546 | 0 | - | 2.3 | 596,325 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 261,546 | 5,102,340 | - | - | Class B Common Stock | ||
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 256,579 | 1,367,905 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Lexeo Therapeutics Inc | Kyle Rasbach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 245,250 | 245,250 | - | - | Stock Option (right to buy) | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 17 Jan 2025 | 241,229 | 365,127 | - | 2.3 | 550,002 | Common Stock |
| Anterix Inc | Scott A. Lang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 191,326 | 191,326 | - | - | Stock Option (Right to Buy) | |
| Anterix Inc | Scott A. Lang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 191,326 | 191,326 | - | - | Stock Option (Right to Buy) | |
| CorMedix Inc | Joseph Todisco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 187,500 | 495,528 (1%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Edward N. Pick | Director, Chairman and CEO | Other type of transaction at price $ 136.31 per share. | 17 Jan 2025 | 181,976 | 620,419 (0%) | 0% | 136.3 | 24,804,239 | Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 164,493 | 164,493 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.26 per share. | 17 Jan 2025 | 164,493 | 0 | - | 2.3 | 371,754 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 164,493 | 4,937,847 | - | - | Class B Common Stock | ||
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.47 per share. | 17 Jan 2025 | 150,000 | 213,186,477 (31%) | 0% | 1.5 | 220,425 | Common Stock |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 148,791 | 148,791 | - | - | Restricted Stock Units | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 147,354 | 1,299,698 (0%) | 0% | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 17 Jan 2025 | 144,000 | 3,774,971 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 17 Jan 2025 | 144,000 | 144,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 17 Jan 2025 | 144,000 | 4,086,364 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 17 Jan 2025 | 144,000 | 144,000 | - | 0 | Class A Common Stock | ||
| Flowco Holdings Inc (Class A) | Joseph R. Edwards | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 134,792 | 134,792 | - | 0 | Class A Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 131,624 | 996,803 (0%) | 0% | 0 | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2025 | 131,624 | 0 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharma Inc | Cedric Francois | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 130,662 | 432,070 (0%) | 0% | 0 | Common Stock | |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 120,542 | 4,817,305 | - | - | Class B Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | 17 Jan 2025 | 120,542 | 120,542 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.26 per share. | 17 Jan 2025 | 120,542 | 0 | - | 2.3 | 272,425 | Class A Common Stock |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.44 per share. | 17 Jan 2025 | 105,833 | 33,919,486 (50%) | 0% | 7.4 | 787,398 | Common Stock |
| Viemed Healthcare Inc | Michael Moore | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 102,642 | 102,642 | - | - | Restricted Stock Units | |
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 101,093 | 1,266,812 (0%) | 0% | 43.1 | 4,352,054 | Common Stock, $0.01 Par Value Per Share |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 100,000 | 300,000 (0%) | 0% | 0 | Common Stock - Performance Based | |
| Surrozen Inc | Craig C. Parker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 99,419 | 960,816 | - | 0 | Common Stock | |
| Innovative Soln And Support Inc | Christopher Harborne | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.82 per share. | 17 Jan 2025 | 98,600 | 2,501,169 (14%) | 0% | 10.8 | 1,066,911 | Common Stock, par value $0.001 per share |
| Entergy | Andrew S. Marsh | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 91,954 | 394,258 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Phillip P. Chan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 90,832 | 90,832 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Phillip P. Chan | Director, Chief Executive Officer | 17 Jan 2025 | 90,832 | 1,243,195 (3%) | 0% | 1 | 90,832 | Common Stock | |
| Cytosorbents Corp | Phillip P. Chan | Director, Chief Executive Officer | 17 Jan 2025 | 90,832 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Phillip P. Chan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 90,832 | 90,832 | - | - | Series B Right Warrants | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 144.33 per share. | 17 Jan 2025 | 84,921 | 915,852 | - | 144.3 | 12,256,648 | Class A Common Stock |
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 83,705 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 83,705 | 1,350,517 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| OmniAb Inc | Matthew W. Foehr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 77,003 | 3,791,450 | - | 0 | Common Stock | |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 74,836 | 322,535 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Stephane Biguet | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 74,836 | 266,392 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Sonida Senior Living Inc | Michael C. Fryar | SVP-Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jan 2025 | 74,060 | 11,206 (0%) | 0% | 0 | Common Stock | |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Sale of securities on an exchange or to another person at price $ 44.19 per share. | 17 Jan 2025 | 73,097 | 234,626 (0%) | 0% | 44.2 | 3,230,156 | Common Stock, $0.01 Par Value Per Share |
| Rexford Industrial Realty Inc | Howard Schwimmer | Director, Co-CEO, Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 70,512 | 751,019 | - | - | LTIP Units | |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 70,512 | 692,933 | - | - | LTIP Units | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 69,232 | 69,232 | - | - | Performance Stock Units | |
| Equity Residential - REIT | Mark J. Parrell | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 68,655 | 68,655 | - | - | Restricted Units | |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 68,420 | 288,261 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 68,420 | 280,623 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Calumet Specialty Products Partners L.P. - Unit | James S. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 66,573 | 394,632 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | James S. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 66,573 | 0 | - | - | Restricted Stock Units | |
| Xenia Hotels & Resorts Inc | Atish Shah | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 65,887 | 46,808 | - | - | LTIP Units | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 143.52 per share. | 17 Jan 2025 | 63,993 | 807,076 | - | 143.5 | 9,184,275 | Class A Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 144.00 per share. | 17 Jan 2025 | 61,834 | 1,022,579 | - | 144 | 8,904,096 | Class A Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 142.57 per share. | 17 Jan 2025 | 61,296 | 743,083 | - | 142.6 | 8,738,971 | Class A Common Stock |
| Omega Healthcare Investors Inc | C. Taylor Pickett | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 59,928 | 695,129 | - | - | Profits Interest Units | |
| Flowco Holdings Inc (Class A) | John T. Gatlin | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 57,292 | 57,292 | - | 0 | Class A Common Stock | |
| Calumet Specialty Products Partners L.P. - Unit | Amy M. Schumacher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 55,950 | 242,244 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Amy M. Schumacher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 55,950 | 0 | - | - | Restricted Stock Unit | |
| Incyte | Herve Hoppenot | Director, Chairman / CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 55,510 | 55,510 | - | - | Employee Stock Option (right to buy) | |
| Flowco Holdings Inc (Class A) | Brooks Mims Talton III | EVP, Natural Gas Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 54,167 | 54,167 | - | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 52,419 | 430,517 | - | 11.2 | 587,150 | Common Stock |
| Morgan Stanley | Daniel A. Simkowitz | Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 51,256 | 499,238 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Andrew M. Saperstein | Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 51,256 | 384,859 (0%) | 0% | 0 | Common Stock | |
| Flowco Holdings Inc (Class A) | Jonathan W. Byers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 50,208 | 50,208 | - | 0 | Class A Common Stock | |
| Sunrun Inc | Lynn Jurich | Director | Sale of securities on an exchange or to another person at price $ 9.59 per share. | 17 Jan 2025 | 50,000 | 991,753 (0%) | 0% | 9.6 | 479,340 | Common Stock |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Sale of securities on an exchange or to another person at price $ 43.94 per share. | 17 Jan 2025 | 50,000 | 184,626 (0%) | 0% | 43.9 | 2,197,000 | Common Stock, $0.01 Par Value Per Share |
| Flowco Holdings Inc (Class A) | Joseph R. Edwards | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 24.00 per share. | 17 Jan 2025 | 50,000 | 184,792 | - | 24 | 1,200,000 | Class A Common Stock |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 50,000 | 156,000 (0%) | 0% | 0 | Common Stock - Restricted Stock | |
| Ironwood Pharma Inc (Class A) | Michael Shetzline | SVP, CMO, Head-Res&Drug | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 48,224 | 461,943 (0%) | 0% | 0 | Class A Common Stock | |
| Genpact Ltd | N. V. Tyagarajan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share. | 17 Jan 2025 | 47,972 | 713,511 (0%) | 0% | 43.3 | 2,079,106 | Common Shares |
| Graco Inc | Mark W. Sheahan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 47,130 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Graco Inc | Mark W. Sheahan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.79 per share. | 17 Jan 2025 | 47,130 | 125,712 (0%) | 0% | 24.8 | 1,168,513 | Common Stock |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 46,572 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 46,572 | 219,182 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Apellis Pharma Inc | Timothy E. Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 45,929 | 132,299 (0%) | 0% | 0 | Common Stock | |
| OmniAb Inc | Charles S. Berkman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 45,294 | 368,679 | - | 0 | Common Stock | |
| Schlumberger | Stephane Biguet | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.87 per share. | 17 Jan 2025 | 45,000 | 206,586 (0%) | 0% | 43.9 | 1,974,150 | Common Stock, $0.01 Par Value Per Share |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 143.39 per share. | 17 Jan 2025 | 44,893 | 960,745 | - | 143.4 | 6,437,207 | Class A Common Stock |
| Morgan Stanley | Eric F. Grossman | Chief Legal/Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 43,947 | 246,266 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Sharon Yeshaya | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 43,947 | 154,393 (0%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | Jeremy Trahan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 43,944 | 43,944 | - | - | Restricted Stock Units | |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 17 Jan 2025 | 43,200 | 537,349 | - | 15.4 | 664,848 | Class A Common Stock |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 43.96 per share. | 17 Jan 2025 | 43,161 | 235,024 (0%) | 0% | 44.0 | 1,897,358 | Common Stock, $0.01 Par Value Per Share |
| Xenia Hotels & Resorts Inc | Atish Shah | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 42,826 | 370,805 (0%) | 0% | - | Common Shares | |
| Schlumberger | Gavin Rennick | President New Energy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,764 | 89,119 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,764 | 76,185 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Apellis Pharma Inc | David Watson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,762 | 148,317 (0%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 17 Jan 2025 | 42,384 | 914,029 | - | 0.8 | 33,907 | Common Stock |
| U.S. Energy Corp | Ryan L. Smith | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.31 per share. | 17 Jan 2025 | 42,301 | 832,749 (59%) | 3% | 2.3 | 97,715 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Harmit J. Singh | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,261 | 320,010 (0%) | 0% | 0 | Class A Common Stock | |
| OmniAb Inc | Matthew W. Foehr | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 17 Jan 2025 | 41,811 | 3,749,639 | - | 3.2 | 135,468 | Common Stock |
| Rekor Systems Inc | David Desharnais | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.60 per share. | 17 Jan 2025 | 40,971 | 988,190 (4%) | 0% | 1.6 | 65,554 | Common Stock |
| Lexeo Therapeutics Inc | Kyle Rasbach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,875 | 40,875 | - | 0 | Common Stock | |
| Incyte | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,289 | 40,289 | - | - | Employee Stock Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,187 | 324,848 (0%) | 0% | 0 | Class A Common Stock | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 40,068 | 40,068 | - | - | Restricted Stock Units | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 40,068 | 227,276 | - | - | Common Shares | |
| Morgan Stanley | Edward N. Pick | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 40,052 | 802,395 (0%) | 0% | 135.8 | 5,439,462 | Common Stock |
| Viemed Healthcare Inc | Trae Fitzgerald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 39,949 | 39,949 | - | - | Restricted Stock Units | |
| Apellis Pharma Inc | Caroline Baumal | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 39,594 | 93,301 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Daniel A. Simkowitz | Co-President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 38,878 | 460,360 (0%) | 0% | 135.8 | 5,280,021 | Common Stock |
| Entergy | Andrew S. Marsh | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.99 per share. | 17 Jan 2025 | 38,528 | 355,730 (0%) | 0% | 82.0 | 3,158,911 | Common Stock |
| Flowco Holdings Inc (Class A) | Chad Roberts | EVP, Production Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 37,500 | 37,500 | - | 0 | Class A Common Stock | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 37,198 | 37,198 | - | - | Phantom Share Units | |
| Apellis Pharma Inc | Nur Nicholson | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 36,426 | 88,437 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Edward N. Pick | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 35,632 | 842,447 (0%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | Jerome Cambre | Vice President of Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 35,155 | 35,155 | - | - | Restricted Stock Units | |
| Surrozen Inc | Yang Li | Exec. Vice President, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 35,000 | 35,000 | - | - | Option (right to buy) | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 35,000 | 35,000 | - | - | Options to buy common stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2025 | 33,864 | 8,925 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 33,864 | 42,789 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 33,864 | 266,477 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2025 | 33,864 | 286,733 (0%) | 0% | - | Class A Common Stock | ||
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 32,938 | 1,317,579 (0%) | 0% | 43.1 | 1,417,981 | Common Stock, $0.01 Par Value Per Share |
| Summit Midstream Corp | J. Heath Deneke | Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 32,755 | 278,761 (0%) | 0% | - | Common Stock | |
| Summit Midstream Corp | J. Heath Deneke | Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 32,755 | 295,004 | - | - | Corporation Restricted Stock Units | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 433,988 (1%) | 0% | 1 | 32,625 | Common Stock | |
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | 17 Jan 2025 | 32,625 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Peter J. Mariani | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 32,625 | 32,625 | - | - | Series A Right Warrants | |
| Fortinet | Michael Xie | Director, VP, ENGINEERING & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 32,034 | 32,034 | - | - | Performance Stock Units | |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 31,990 | 934,051 (1%) | 0% | 0 | Class A Common Stock | |
| Carvana Co. (Class A) | Mark Jenkins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 31,816 | 220,913 (0%) | 0% | 0 | Class A Common Stock | |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 31,816 | 247,895 (0%) | 0% | 0 | Class A Common Stock | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 665,168 (1%) | 0% | 1 | 31,760 | Common Stock | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series A Right Warrants | |
| Joby Aviation Inc | Bonny W. Simi | President of Operations | Sale of securities on an exchange or to another person at price $ 8.33 per share. | 17 Jan 2025 | 31,489 | 137,097 | - | 8.3 | 262,303 | Common Stock |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2025 | 31,136 | 8,925 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 31,136 | 40,061 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 31,136 | 235,341 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 120.10 per share. | 17 Jan 2025 | 31,136 | 252,869 (0%) | 0% | 120.1 | 3,739,381 | Class A Common Stock |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2025 | 31,136 | 284,005 (0%) | 0% | - | Class A Common Stock | ||
| Graco Inc | Mark W. Sheahan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.14 per share. | 17 Jan 2025 | 30,268 | 95,444 (0%) | 0% | 85.1 | 2,577,018 | Common Stock |
| Lovesac Co | Jack A. Krause | Director | Sale of securities on an exchange or to another person at price $ 26.33 per share. | 17 Jan 2025 | 30,000 | 147,849 (1%) | 0% | 26.3 | 789,900 | Common Stock, $0.00001 par value |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 29,619 | 292,916 (0%) | 0% | 43.1 | 1,275,098 | Common Stock, $0.01 Par Value Per Share |
| Schlumberger | Stephane Biguet | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 29,613 | 236,779 (0%) | 0% | 43.1 | 1,274,840 | Common Stock, $0.01 Par Value Per Share |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 29,559 | 455,084 (0%) | 0% | 0 | Ordinary Shares | |
| Outset Medical Inc | John L. Brottem | General Counsel | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 17 Jan 2025 | 29,474 | 183,867 | - | 0.8 | 23,579 | Common Stock |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 17 Jan 2025 | 29,474 | 262,776 | - | 0.8 | 23,579 | Common Stock |
| Morgan Stanley | Charles Aubrey Smith | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 29,328 | 158,045 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Michael A. Pizzi | Head Technology & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 29,328 | 174,033 (0%) | 0% | 0 | Common Stock | |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 29,327 | 256,965 (0%) | 0% | 43.0 | 1,262,527 | Common Stock, $0.01 Par Value Per Share |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 17 Jan 2025 | 29,158 | 4,164,789 | - | 0.9 | 25,000 | Common Stock, par value $.001 |
| Apellis Pharma Inc | Karen Lewis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,508 | 72,366 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharma Inc | Mark Jeffrey DeLong | Chief Business & Strat Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,508 | 86,069 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,470 | 218,916 (0%) | 0% | 0 | Class A Common Stock | |
| Vital Farms Inc | Joanne Bal | GC, SEC. AND HEAD OF IMPACT | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 17 Jan 2025 | 28,246 | 59,371 | - | 45.1 | 1,273,895 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,202 | 28,202 | - | - | Employee Stock Option (right to buy) | |
| Fortinet | Keith Jensen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,156 | 28,156 | - | - | Performance Stock Units | |
| Cingulate Inc | Shane J. Schaffer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 27,638 | 27,638 | - | - | Stock Option (right to Buy) | |
| OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 27,585 | 228,246 | - | 0 | Common Stock | |
| Morgan Stanley | Andrew M. Saperstein | Co-President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 27,032 | 357,827 (0%) | 0% | 135.8 | 3,671,216 | Common Stock |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 26,939 | 26,939 | - | - | Restricted Stock Units | |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 26,939 | 250,823 | - | - | Common Shares | |
| Viemed Healthcare Inc | Michael Moore | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 26,939 | 153,281 | - | - | Common Shares | |
| Viemed Healthcare Inc | Michael Moore | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 26,939 | 26,939 | - | - | Restricted Stock Units | |
| Entergy | Marcus V. Brown | EVP & General Counsel | 17 Jan 2025 | 26,041 | 62,221 (0%) | 0% | 0 | Common Stock | ||
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,661 | 25,661 | - | - | Phantom Share Units | |
| Viemed Healthcare Inc | Michael Moore | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,661 | 25,661 | - | - | Phantom Share Units | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,516 | 25,516 | - | - | Employee Stock Option (right to buy) | |
| OmniAb Inc | Charles S. Berkman | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 17 Jan 2025 | 25,489 | 343,190 | - | 3.2 | 82,584 | Common Stock |
| Coinbase Global Inc (Class A) | Frederick Ernest Ehrsam | Director | 17 Jan 2025 | 25,194 | 5,995,417 | - | - | Class B Common Stock | ||
| Coinbase Global Inc (Class A) | Frederick Ernest Ehrsam | Director | 17 Jan 2025 | 25,194 | 25,194 | - | 0 | Class A Common Stock | ||
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 25,120 | 37,680 | - | - | Restricted Stock Unit Grant | |
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 25,120 | 5,187,623 (15%) | 0% | 0 | Common Stock | |
| Lightwave Logic Inc | Thomas E. Zelibor | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.80 per share. | 17 Jan 2025 | 25,000 | 231,889 | - | 0.8 | 20,000 | Common Stock |
| Lightwave Logic Inc | Thomas E. Zelibor | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 375,000 | - | - | Employee Stock Option (Right to Buy) | |
| Schlumberger | Vijay Kasibhatla | Director, M&A | Sale of securities on an exchange or to another person at price $ 43.94 per share. | 17 Jan 2025 | 25,000 | 49,595 (0%) | 0% | 43.9 | 1,098,500 | Common Stock, $0.01 Par Value Per Share |
| CorMedix Inc | Myron Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 176,034 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Alan W. Dunton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 40,250 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Steven W. Lefkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 100,498 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 78,473 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Gregory Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 | - | - | Options to buy common stock | |
| Upexi Inc | Lawrence H. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 | - | - | Options to buy common stock | |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 24,414 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 24,414 | 317,330 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Stephane Biguet | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 24,414 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Stephane Biguet | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 24,414 | 261,193 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Entergy | Peter S. Norgeot | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 24,319 | 95,295 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Joseph Todisco | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share. | 17 Jan 2025 | 23,977 | 471,551 (1%) | 0% | 12.2 | 291,800 | Common Stock |
| Omega Healthcare Investors Inc | Robert O. Stephenson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 23,641 | 291,391 | - | - | Profits Interest Units | |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 23,613 | 264,648 (0%) | 0% | 43.1 | 1,016,540 | Common Stock, $0.01 Par Value Per Share |
| Morgan Stanley | Raja J. Akram | Deputy Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 23,462 | 111,905 (0%) | 0% | 0 | Common Stock | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Harmit J. Singh | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.37 per share. | 17 Jan 2025 | 22,980 | 297,030 (0%) | 0% | 17.4 | 399,163 | Class A Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 17 Jan 2025 | 22,946 | 193,456,254 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 17 Jan 2025 | 22,946 | 22,946 (0%) | 0% | 0 | Class A Common Stock | ||
| Morgan Stanley | Eric F. Grossman | Chief Legal/Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 22,714 | 223,552 (0%) | 0% | 135.8 | 3,084,788 | Common Stock |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 22,321 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 22,321 | 286,969 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 22,321 | 279,286 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 22,321 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Morgan Stanley | Mandell L. Crawley | Chief Client Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 22,019 | 65,942 (0%) | 0% | 0 | Common Stock | |
| Fortinet | John Whittle | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 21,982 | 21,982 | - | - | Performance Stock Units | |
| Cytosorbents Corp | Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 123,807 (0%) | 0% | 1 | 21,950 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series B Right Warrants | |
| Outset Medical Inc | Marc Nash | SVP Operations and R&D | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 17 Jan 2025 | 21,590 | 206,243 | - | 0.8 | 17,272 | Common Stock |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 21,063 | 51,221 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors Inc | Matthew Gourmand | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 20,645 | 146,118 | - | - | Profits Interest Units | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 20,636 | 64,995 (0%) | 0% | 43.1 | 888,380 | Common Stock, $0.01 Par Value Per Share |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 143.51 per share. | 17 Jan 2025 | 20,624 | 830,931 | - | 143.5 | 2,959,750 | Class A Common Stock |
| Carvana Co. (Class A) | Paul Breaux | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 20,266 | 153,619 (0%) | 0% | 0 | Class A Common Stock | |
| Morgan Stanley | Charles Aubrey Smith | Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 20,237 | 137,808 (0%) | 0% | 135.8 | 2,748,387 | Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 20,148 | 262,608 | - | 11.2 | 225,680 | Common Stock |
| Incyte | Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 20,144 | 20,144 | - | - | Employee Stock Option (right to buy) | |
| Akebia Therapeutics Inc | Ronald E. Frieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 17 Jan 2025 | 20,100 | 93,800 (0%) | 0% | 0.5 | 9,045 | Common Stock |
| Akebia Therapeutics Inc | Ronald E. Frieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 20,100 | 0 | - | - | Stock Option (Right to buy) | |
| Applied Digital Corp | Richard N. Nottenburg | Director | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 17 Jan 2025 | 20,000 | 342,923 | - | 8.9 | 177,000 | Common Stock |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 19,225 | 185,336 (0%) | 0% | 0 | Class A Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 120.32 per share. | 17 Jan 2025 | 18,864 | 252,869 (0%) | 0% | 120.3 | 2,269,752 | Class A Common Stock |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Jan 2025 | 18,629 | 200,553 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Elizabeth O’Neill | EVP & Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 18,594 | 122,844 (0%) | 0% | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | 17 Jan 2025 | 18,478 | 194,574 | - | 11.2 | 206,974 | Common Stock | |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 17 Jan 2025 | 18,449 | 895,580 | - | 0.8 | 14,759 | Common Stock |
| Coinbase Global Inc (Class A) | Frederick Ernest Ehrsam | Director | Sale of securities on an exchange or to another person at price $ 298.45 per share. | 17 Jan 2025 | 18,445 | 6,749 | - | 298.5 | 5,504,921 | Class A Common Stock |
| Priority Technology Holdings | Ranjana Ram | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.44 per share. | 17 Jan 2025 | 18,385 | 693,004 (1%) | 0% | 7.4 | 136,784 | Common Stock |
| Morgan Stanley | Michael A. Pizzi | Head Technology & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 17,855 | 156,178 (0%) | 0% | 135.8 | 2,424,888 | Common Stock |
| Schlumberger | Howard Guild | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 17,104 | 41,832 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Vijay Kasibhatla | Director, M&A | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 17,104 | 79,679 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Kevin Fyfe | VP & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 17,104 | 51,353 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Gavin Rennick | President New Energy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 17,006 | 72,113 (0%) | 0% | 43.0 | 732,108 | Common Stock, $0.01 Par Value Per Share |
| Omega Healthcare Investors Inc | Vikas Gupta | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 16,849 | 142,322 | - | - | Profits Interest Units | |
| Piper Sandler Co`s | Jonathan J. Doyle | Director, Hd of Financial Services Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2025 | 16,563 | 132,532 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | 17 Jan 2025 | 16,233 | 403,025 (1%) | 0% | 1 | 16,233 | Common Stock | |
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | 17 Jan 2025 | 16,233 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 16,233 | 16,233 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 16,233 | 16,233 | - | - | Series B Right Warrants | |
| Vital Farms Inc | Joanne Bal | GC, SEC. AND HEAD OF IMPACT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.56 per share. | 17 Jan 2025 | 15,993 | 87,617 | - | 25.6 | 408,781 | Common Stock |
| Vital Farms Inc | Joanne Bal | GC, SEC. AND HEAD OF IMPACT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 15,993 | 56,493 | - | - | Employee Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 15,936 | 211,558 | - | 11.2 | 178,501 | Common Stock |
| Cytosorbents Corp | Michael G. Bator | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 15,879 | 15,879 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Michael G. Bator | Director | 17 Jan 2025 | 15,879 | 141,273 (0%) | 0% | 1 | 15,879 | Common Stock | |
| Cytosorbents Corp | Michael G. Bator | Director | 17 Jan 2025 | 15,879 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Michael G. Bator | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 15,879 | 15,879 | - | - | Series A Right Warrants | |
| Flowco Holdings Inc (Class A) | Ben A. Guill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,625 | 15,625 | - | 0 | Class A Common Stock | |
| Flowco Holdings Inc (Class A) | Paul William Hobby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,625 | 15,625 | - | 0 | Class A Common Stock | |
| Flowco Holdings Inc (Class A) | Cynthia Lynn Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,625 | 15,625 | - | 0 | Class A Common Stock | |
| Flowco Holdings Inc (Class A) | Alexander Chmelev | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,625 | 15,625 | - | 0 | Class A Common Stock | |
| Flowco Holdings Inc (Class A) | Jonathan B. Fairbanks | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,625 | 15,625 | - | 0 | Class A Common Stock | |
| OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 17 Jan 2025 | 15,526 | 212,720 | - | 3.2 | 50,304 | Common Stock |
| Equity Residential - REIT | Alexander Brackenridge | Executive Vice President & CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,308 | 73,997 (0%) | 0% | 0 | Common Shares Of Beneficial Interest | |
| Schlumberger | Carmen Rando Bejar | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,114 | 38,136 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Apellis Pharma Inc | Pascal Deschatelets | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 15,045 | 1,152,490 (1%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Matthew W. Tonn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 17 Jan 2025 | 14,896 | 251,479 (1%) | 0% | 12.4 | 184,264 | Common Stock |
| Incyte | Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,772 | 14,772 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,772 | 14,772 | - | - | Employee Stock Option (right to buy) | |
| 60 Degrees Pharma Inc | Geoffrey S. Dow | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,394 | 108,974 | - | 0 | Common Stock | |
| Integer Holdings Corp | Joseph W. Dziedzic | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,184 | 14,184 | - | - | Restricted Stock Units | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 14,114 | 0 | - | - | Phantom Share Units | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.15 per share. | 17 Jan 2025 | 14,114 | 214,721 | - | 8.1 | 115,029 | Common Shares |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 14,114 | 228,835 | - | - | Common Shares | |
| Entergy | Kimberly Cook-Nelson | EVP & Chief Nuclear Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 13,963 | 34,383 (0%) | 0% | 0 | Common Stock | |
| Schlumberger | Gavin Rennick | President New Energy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 13,951 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Gavin Rennick | President New Energy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 13,951 | 86,064 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 13,951 | 78,946 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 13,951 | 0 | - | - | RSU (Restricted Stock Unit) | |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.62 per share. | 17 Jan 2025 | 13,840 | 441,244 (0%) | 0% | 122.6 | 1,697,061 | Ordinary Shares |
| Data Storage Corp | Charles M. Piluso | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 13,747 | 13,747 | - | - | Stock Option to Purchase Common Stock | |
| Schlumberger | Howard Guild | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 43.87 per share. | 17 Jan 2025 | 13,568 | 24,728 (0%) | 0% | 43.9 | 595,228 | Common Stock, $0.01 Par Value Per Share |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 13,475 | 164,209 (0%) | 0% | 0 | Class A Common Stock | |
| Morgan Stanley | Sharon Yeshaya | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 13,443 | 140,950 (0%) | 0% | 135.8 | 1,825,694 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 13,270 | 80,774 | - | 11.2 | 148,639 | Common Stock |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 13,256 | 293,157 | - | 0 | Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.70 per share. | 17 Jan 2025 | 13,095 | 307,536 | - | 30.7 | 402,017 | Class A Common Stock |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.70 per share. | 17 Jan 2025 | 13,095 | 307,536 | - | 30.7 | 402,017 | Class A Common Stock |
| Entergy | Kathryn A. Collins | SVP & Chief H.R. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 13,002 | 46,748 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Raja J. Akram | Deputy Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.81 per share. | 17 Jan 2025 | 12,966 | 98,939 (0%) | 0% | 135.8 | 1,760,912 | Common Stock |
| Omega Healthcare Investors Inc | Gail D. Makode | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,960 | 138,433 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Neal A. Ballew | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,960 | 119,067 | - | - | Profits Interest Units | |
| Equity Residential - REIT | Michael L. Manelis | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,908 | 12,908 | - | - | Restricted Units | |
| Apellis Pharma Inc | James George Chopas | VP/Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,591 | 49,234 (0%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.15 per share. | 17 Jan 2025 | 12,555 | 214,721 | - | 8.1 | 102,323 | Common Shares |
| Flowco Holdings Inc (Class A) | Joel Lambert | SVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,500 | 12,500 | - | 0 | Class A Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.69 per share. | 17 Jan 2025 | 12,352 | 66,967 (0%) | 0% | 72.7 | 897,867 | Common Stock |
| Vital Farms Inc | Kathryn McKeon | CMO and GM, Butter | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share. | 17 Jan 2025 | 12,300 | 58,503 | - | 3.7 | 45,200 | Common Stock |
| Vital Farms Inc | Kathryn McKeon | CMO and GM, Butter | Sale of securities on an exchange or to another person at price $ 44.05 per share. | 17 Jan 2025 | 12,300 | 46,203 | - | 44.1 | 541,815 | Common Stock |
| Vital Farms Inc | Kathryn McKeon | CMO and GM, Butter | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 12,300 | 0 | - | - | Employee Stock Option (right to buy) | |
| Phillips 66 | Vanessa L. Allen Sutherland | EVP, GC and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.86 per share. | 17 Jan 2025 | 12,291 | 42,033 (0%) | 0% | 119.9 | 1,473,162 | Common Stock |
| Vital Farms Inc | Joanne Bal | GC, SEC. AND HEAD OF IMPACT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 12,253 | 24,505 | - | - | Employee Stock Option (right to buy) | |
| Vital Farms Inc | Joanne Bal | GC, SEC. AND HEAD OF IMPACT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.31 per share. | 17 Jan 2025 | 12,253 | 71,624 | - | 15.3 | 187,593 | Common Stock |
| Incyte | Sheila A Denton | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 12,086 | 12,086 | - | - | Employee Stock Option (right to buy) | |
| Flowco Holdings Inc (Class A) | Jonathan W. Byers | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 24.00 per share. | 17 Jan 2025 | 12,000 | 62,208 | - | 24 | 288,000 | Class A Common Stock |
| Data Storage Corp | Charles M. Piluso | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,976 | 389,358 | - | - | Common Stock | |
| Equity Residential - REIT | Robert A. Garechana | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,915 | 11,915 | - | - | Restricted Units | |
| 60 Degrees Pharma Inc | Tyrone Miller | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,626 | 26,370 | - | 0 | Common Stock | |
| Entergy | Phillip R. May | Officer Under Sec. 16 Rules | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,543 | 43,321 (0%) | 0% | 0 | Common Stock | |
| Cingulate Inc | Jennifer L. Callahan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 11,539 | 11,539 | - | - | Stock Option (right to Buy) | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.93 per share. | 17 Jan 2025 | 11,086 | 21,197 | - | 46.9 | 520,297 | Class A Common Stock |
| Viemed Healthcare Inc | Jeremy Trahan | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 10,986 | 10,986 | - | - | Phantom Share Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.94 per share. | 17 Jan 2025 | 10,786 | 20,988 | - | 46.9 | 506,255 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.63 per share. | 17 Jan 2025 | 10,750 | 31,885 | - | 46.6 | 501,245 | Class A Common Stock |
| Entergy | Peter S. Norgeot | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.99 per share. | 17 Jan 2025 | 10,699 | 84,596 (0%) | 0% | 82.0 | 877,211 | Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 17 Jan 2025 | 10,454 | 1,825,675 (23%) | 0% | 17.2 | 179,913 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.92 per share. | 17 Jan 2025 | 10,382 | 21,272 | - | 46.9 | 487,155 | Class A Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 17 Jan 2025 | 10,230 | 70,544 | - | 11.0 | 112,462 | Common Stock |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 10,017 | 10,017 | - | - | Phantom Share Units | |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.15 per share. | 17 Jan 2025 | 10,017 | 214,721 | - | 8.2 | 81,639 | Common Shares |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 10,017 | 224,738 | - | - | Common Shares | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.63 per share. | 17 Jan 2025 | 10,006 | 31,601 | - | 46.6 | 466,546 | Class A Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 17 Jan 2025 | 10,000 | 922,334 (4%) | 0% | 2.6 | 25,700 | Common Stock |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.67 per share. | 17 Jan 2025 | 10,000 | 1,651,905 (6%) | 0% | 28.7 | 286,700 | Common Stock |
| Argan Inc | John R. Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 10,000 | 21,500 | - | - | Option to Purchase Common Stock | |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 30.76 per share. | 17 Jan 2025 | 10,000 | 5,693,182 (3%) | 0% | 30.8 | 307,585 | Common Stock |
| Innovative Soln And Support Inc | Christopher Harborne | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 17 Jan 2025 | 10,000 | 2,599,769 (15%) | 0% | 10.2 | 101,569 | Common Stock, par value $0.001 per share |
| Viemed Healthcare Inc | Trae Fitzgerald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 9,987 | 9,987 | - | - | Phantom Share Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 17 Jan 2025 | 9,939 | 40,262 | - | 46.2 | 459,061 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.63 per share. | 17 Jan 2025 | 9,859 | 31,654 | - | 46.6 | 459,705 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.64 per share. | 17 Jan 2025 | 9,823 | 32,006 | - | 46.6 | 458,109 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.91 per share. | 17 Jan 2025 | 9,728 | 22,278 | - | 46.9 | 456,314 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.90 per share. | 17 Jan 2025 | 9,668 | 22,217 | - | 46.9 | 453,434 | Class A Common Stock |
| Entergy | Marcus V. Brown | EVP & General Counsel | 17 Jan 2025 | 9,616 | 52,605 (0%) | 0% | 82.0 | 788,416 | Common Stock | |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 9,607 | 307,723 (0%) | 0% | 43.0 | 413,581 | Common Stock, $0.01 Par Value Per Share |
| Schlumberger | Stephane Biguet | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 9,607 | 251,586 (0%) | 0% | 43.0 | 413,581 | Common Stock, $0.01 Par Value Per Share |
| Viemed Healthcare Inc | Trae Fitzgerald | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,591 | 9,590 | - | - | Restricted Stock Units | |
| Viemed Healthcare Inc | Trae Fitzgerald | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,591 | 76,019 | - | - | Common Shares | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.92 per share. | 17 Jan 2025 | 9,501 | 22,100 | - | 46.9 | 445,755 | Class A Common Stock |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,488 | 0 | - | - | Phantom Share Units | |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 8.15 per share. | 17 Jan 2025 | 9,488 | 242,059 | - | 8.1 | 77,327 | Common Shares |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,488 | 251,547 | - | - | Common Shares | |
| Viemed Healthcare Inc | Michael Moore | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,488 | 154,007 | - | - | Common Shares | |
| Viemed Healthcare Inc | Michael Moore | President | Sale or transfer of securities back to the company at price $ 8.15 per share. | 17 Jan 2025 | 9,488 | 144,519 | - | 8.1 | 77,327 | Common Shares |
| Viemed Healthcare Inc | Michael Moore | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,488 | 0 | - | - | Phantom Share Units | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 9,446 | 85,631 (0%) | 0% | 0 | Common Stock, $0.01 Par Value Per Share | |
| Summit Midstream Corp | J. Heath Deneke | Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.57 per share. | 17 Jan 2025 | 9,435 | 269,326 (0%) | 0% | 41.6 | 392,213 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.17 per share. | 17 Jan 2025 | 9,395 | 40,821 | - | 46.2 | 433,756 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 17 Jan 2025 | 9,338 | 13,622 | - | 47.3 | 441,424 | Class A Common Stock |
| Cingulate Inc | Laurie A. Myers | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 9,319 | 9,319 | - | - | Stock Option (right to Buy) | |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.99 per share. | 17 Jan 2025 | 9,309 | 41,912 (0%) | 0% | 82.0 | 763,245 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.64 per share. | 17 Jan 2025 | 9,298 | 31,774 | - | 46.6 | 433,697 | Class A Common Stock |
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | 17 Jan 2025 | 9,251 | 131,144 | - | 0 | Class A Common Stock | ||
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,251 | 27,753 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 17 Jan 2025 | 9,251 | 121,893 | - | 65 | 601,315 | Class A Common Stock |
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 9,251 | 9,251 | - | - | Class B Common Stock | |
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | 17 Jan 2025 | 9,251 | 0 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.90 per share. | 17 Jan 2025 | 9,157 | 22,960 | - | 46.9 | 429,432 | Class A Common Stock |
| Outset Medical Inc | John L. Brottem | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 9,090 | 214,118 | - | 0 | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 17 Jan 2025 | 8,856 | 13,244 | - | 47.3 | 418,627 | Class A Common Stock |
| Viemed Healthcare Inc | Jerome Cambre | Vice President of Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 8,789 | 8,789 | - | - | Phantom Share Units | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 17 Jan 2025 | 8,786 | 13,492 | - | 47.3 | 415,327 | Class A Common Stock |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 8,784 | 278,185 (0%) | 0% | 43.0 | 378,151 | Common Stock, $0.01 Par Value Per Share |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 8,784 | 270,502 (0%) | 0% | 43.0 | 378,151 | Common Stock, $0.01 Par Value Per Share |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.14 per share. | 17 Jan 2025 | 8,781 | 41,072 | - | 46.1 | 405,120 | Class A Common Stock |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.15 per share. | 17 Jan 2025 | 8,764 | 242,059 | - | 8.2 | 71,427 | Common Shares |
| Viemed Healthcare Inc | Michael Moore | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.15 per share. | 17 Jan 2025 | 8,762 | 144,519 | - | 8.1 | 71,410 | Common Shares |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 17 Jan 2025 | 8,721 | 13,496 | - | 47.3 | 412,264 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.66 per share. | 17 Jan 2025 | 8,538 | 32,283 | - | 46.7 | 398,346 | Class A Common Stock |
| Viemed Healthcare Inc | Jerome Cambre | Vice President of Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,525 | 82,982 | - | - | Common Shares | |
| Viemed Healthcare Inc | Jerome Cambre | Vice President of Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,525 | 8,525 | - | - | Restricted Stock Units | |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.89 per share. | 17 Jan 2025 | 8,400 | 28,156 (0%) | 0% | 58.9 | 494,676 | Common Stock |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | Sale of securities on an exchange or to another person at price $ 66.02 per share. | 17 Jan 2025 | 8,400 | 19,756 (0%) | 0% | 66.0 | 554,534 | Common Stock |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,400 | 5,060 | - | - | Employee Stock Option (right to buy) | |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 17 Jan 2025 | 8,335 | 225,629 (0%) | 0% | 6.5 | 54,178 | Class A Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,335 | 29,701 | - | - | Employee Stock Option (Right to Buy) | |
| Flowco Holdings Inc (Class A) | Alexander Chmelev | Director | Purchase of securities on an exchange or from another person at price $ 24.00 per share. | 17 Jan 2025 | 8,300 | 23,925 | - | 24 | 199,200 | Class A Common Stock |
| Integer Holdings Corp | Joseph W. Dziedzic | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,235 | 238,323 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Joseph W. Dziedzic | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 8,235 | 8,235 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.12 per share. | 17 Jan 2025 | 8,194 | 41,829 | - | 46.1 | 377,885 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.65 per share. | 17 Jan 2025 | 8,145 | 32,117 | - | 46.7 | 379,998 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.11 per share. | 17 Jan 2025 | 8,122 | 41,513 | - | 46.1 | 374,480 | Class A Common Stock |
| Schlumberger | Vijay Kasibhatla | Director, M&A | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.05 per share. | 17 Jan 2025 | 8,041 | 71,638 (0%) | 0% | 43.0 | 346,165 | Common Stock, $0.01 Par Value Per Share |
| Data Storage Corp | Chris H. Panagiotakos | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 8,019 | 8,019 | - | - | Stock Option to Purchase Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.29 per share. | 17 Jan 2025 | 7,966 | 13,306 | - | 47.3 | 376,720 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 17 Jan 2025 | 7,939 | 41,607 | - | 46.1 | 365,959 | Class A Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 144.92 per share. | 17 Jan 2025 | 7,917 | 1,030,496 | - | 144.9 | 1,147,332 | Class A Common Stock |
| Entergy | Jason Chapman | Officer Under Sec. 16 Rules | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 7,776 | 27,034 (0%) | 0% | 0 | Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.28 per share. | 17 Jan 2025 | 7,757 | 13,231 | - | 47.3 | 366,773 | Class A Common Stock |
| Jazz Pharma PLC | Renee D. Gala | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 7,741 | 63,233 (0%) | 0% | 0 | Ordinary Shares | |
| Argan Inc | John R. Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.15 per share. | 17 Jan 2025 | 7,731 | 16,985 (0%) | 0% | 40.2 | 310,400 | Common Stock |
| Integer Holdings Corp | Joseph W. Dziedzic | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 7,662 | 0 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joseph W. Dziedzic | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 7,662 | 245,985 (0%) | 0% | - | Common Stock | |
| Equity Residential - REIT | Scott J. Fenster | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 7,654 | 40,847 (0%) | 0% | 0 | Common Shares Of Beneficial Interest | |
| Full House Resorts Inc | Lewis A. Fanger | Director, Sr. VP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 7,597 | 196,532 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Lewis A. Fanger | Director, Sr. VP, CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Jan 2025 | 7,597 | 254,658 (0%) | 0% | 5.0 | 38,003 | Common Stock |
| Full House Resorts Inc | Lewis A. Fanger | Director, Sr. VP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. | 17 Jan 2025 | 7,597 | 262,255 (0%) | 0% | 1.4 | 10,408 | Common Stock |
| TWFG Inc (Class A) | Janice E. Zwinggi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.70 per share. | 17 Jan 2025 | 7,592 | 54,231 | - | 30.7 | 233,074 | Class A Common Stock |
| Jazz Pharma PLC | Robert Iannone | EVP, G R&D and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 7,506 | 69,947 (0%) | 0% | 0 | Ordinary Shares | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.06 per share. | 17 Jan 2025 | 7,452 | 42,635 | - | 46.1 | 343,219 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.